The goal of antiretroviral therapy in the management of HIV infection is to improve CD4 cell counts and ↓ viral load. If accomplished, this generally results in slowed progression of the disease, improved quality of life, and ↓ opportunistic infections. Perinatal use of agents also prevents transmission of the virus to the fetus. Post-exposure and pre-exposure prophylaxis with certain antiretrovirals is also recommended.
There's more to see -- the rest of this topic is available only to subscribers.
Vallerand, April Hazard., et al. "Antiretrovirals." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/50927/all/antiretrovirals.
Vallerand AHA, Sanoski CAC, Quiring CC. Antiretrovirals. Davis's Drug Guide. F.A. Davis Company; 2023. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/50927/all/antiretrovirals. Accessed May 31, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Antiretrovirals. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/50927/all/antiretrovirals
Vallerand AHA, Sanoski CAC, Quiring CC. Antiretrovirals [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 May 31]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/50927/all/antiretrovirals.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - antiretrovirals ID - 50927 A1 - Sanoski,Cynthia A, AU - Vallerand,April Hazard, AU - Quiring,Courtney, BT - Davis's Drug Guide UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/50927/all/antiretrovirals PB - F.A. Davis Company ET - 18 DB - Medicine Central DP - Unbound Medicine ER -